Skip to main content
Clinical Trials/JPRN-jRCT1042230119
JPRN-jRCT1042230119
Recruiting
Phase 2

Trial to evaluate the efficacy of vibration positive expiratory pressure therapy in the perioperative period for esophageal cancer - CCOG2302

Kanda Mitsuro0 sites50 target enrollmentDecember 21, 2023

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Kanda Mitsuro
Enrollment
50
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 21, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kanda Mitsuro

Eligibility Criteria

Inclusion Criteria

  • Patients scheduled for minimally invasive esophagectomy for curatively resectable esophageal cancer
  • Patients with an ECOG performance status (PS) of 0, 1, or 2
  • Cases in which the patient's written consent has been obtained

Exclusion Criteria

  • Cases in which split surgery is performed
  • Tracheostomies and cases with permanent tracheal holes
  • Cases of emergency surgery
  • Cases with a history of thoracic radiotherapy
  • Cases with severe lung diseases (interstitial pneumonia, pulmonary fibrosis, severe emphysema, etc.)
  • Patients with a history of clinically problematic mental disorders or central nervous system disorders
  • Cases in which spirometry is not feasible.
  • Patients with a history of pneumothorax
  • Cases in which the principal investigator or physician in charge judges that the patient is not suitable to participate in this study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Vibration positive expiratory pressure... | Clinical Trial